Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by johnny007on Jun 02, 2021 1:51pm
89 Views
Post# 33311749

difficult, but ..

difficult, but .... some progress, I agree with nailbiter regarding the PR company.

Assuming they will work on Aristotle and, OK, the covid tests.

The drive-in (or -by or -up, funny)  covid test PR today, hmm.
Don't know how that works, maybe good way to put the officers to work? /jk :-)

Saw the 0.55 break yesterday. Now traded on 2H 2020 support.

So here is the chance, have it bounce strongly back above .60 and make it go above
the upper BB on some expectations. That would be at least .75.

200dma is still around .85 waiting for Tripp ;-)

I am very critical and negative here, but even the worst stock can bounce every now and then.
Hey, Tripp, make it fly a little. Haha.

I know, not really funny. Bought a few shares .53 for the good old times.
If they follow up with proper Aristotle news, some PR - MAYBE SOME ACTUAL READY TO PURCHASE ADVERTISEMENT (you hear that Tripp) - it should walk back up a chunk.

They need to show Aristotle is real.
Good luck!

<< Previous
Bullboard Posts
Next >>